Atlas Trials

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Clinical trial NCT00545519 · COMPLETED

Trial details

NCT number
NCT00545519
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Or Refractory Multiple Myeloma
Start date
2006-10-01
Primary completion
2008-03-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.